Towards personalized prostate cancer screening
The value of the prostate-specific antigen (PSA) in prostate cancer (PCa) screening is controversial. Contradictory results have been reported in the literature as to whether PSA-based screening reduces mortality. Also, some of the studies published are methodologically flawed. However, evidence con...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2020-01-01
|
| Series: | Advances in Laboratory Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/almed-2019-0027 |
| _version_ | 1797800901203722240 |
|---|---|
| author | Filella Xavier |
| author_facet | Filella Xavier |
| author_sort | Filella Xavier |
| collection | DOAJ |
| description | The value of the prostate-specific antigen (PSA) in prostate cancer (PCa) screening is controversial. Contradictory results have been reported in the literature as to whether PSA-based screening reduces mortality. Also, some of the studies published are methodologically flawed. However, evidence consistently demonstrates that screening programs results in the identification of patients with indolent prostatic tumors which rate has increased. |
| first_indexed | 2024-03-13T04:42:13Z |
| format | Article |
| id | doaj.art-40338db0fb904fad9d9df60386ac12cf |
| institution | Directory Open Access Journal |
| issn | 2628-491X |
| language | English |
| last_indexed | 2024-03-13T04:42:13Z |
| publishDate | 2020-01-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Advances in Laboratory Medicine |
| spelling | doaj.art-40338db0fb904fad9d9df60386ac12cf2023-06-19T05:32:24ZengDe GruyterAdvances in Laboratory Medicine2628-491X2020-01-011119415310.1515/almed-2019-0027Towards personalized prostate cancer screeningFilella Xavier0Department of Biochemistry and Molecular Genetics (CDB), IDIBAPS, Hospital Clínic, Barcelona, Catalonia, SpainThe value of the prostate-specific antigen (PSA) in prostate cancer (PCa) screening is controversial. Contradictory results have been reported in the literature as to whether PSA-based screening reduces mortality. Also, some of the studies published are methodologically flawed. However, evidence consistently demonstrates that screening programs results in the identification of patients with indolent prostatic tumors which rate has increased.https://doi.org/10.1515/almed-2019-0027prostate-specific antigen (psa)screeningprostate cancerphi4kscore |
| spellingShingle | Filella Xavier Towards personalized prostate cancer screening Advances in Laboratory Medicine prostate-specific antigen (psa) screening prostate cancer phi 4kscore |
| title | Towards personalized prostate cancer screening |
| title_full | Towards personalized prostate cancer screening |
| title_fullStr | Towards personalized prostate cancer screening |
| title_full_unstemmed | Towards personalized prostate cancer screening |
| title_short | Towards personalized prostate cancer screening |
| title_sort | towards personalized prostate cancer screening |
| topic | prostate-specific antigen (psa) screening prostate cancer phi 4kscore |
| url | https://doi.org/10.1515/almed-2019-0027 |
| work_keys_str_mv | AT filellaxavier towardspersonalizedprostatecancerscreening |